This Notice of Funding Opportunity (NOFO) is designed to support the comprehensive and well-defined planning of product development strategies. It specifically targets the advancement of next-generation treatments for HIV, including HIV-associated comorbidities, coinfections, and complications, as well as novel preventive strategies against HIV. The grant’s core purpose is to facilitate the critical translation of promising research findings into viable drug products. By providing this support, the NOFO aims to enable the successful preparation and submission of an Investigational New Drug (IND) application to the FDA, thereby accelerating the pathway from scientific discovery to potential clinical use for innovative HIV interventions. This grant focuses solely on strategic planning, not clinical trials.
Opportunity ID: 349870
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-24-029 |
| Funding Opportunity Title: | Planning for Product Development Strategy (R34 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Aug 15, 2023 |
| Last Updated Date: | Dec 30, 2024 |
| Original Closing Date for Applications: | Dec 04, 2026 |
| Current Closing Date for Applications: | Dec 29, 2024 |
| Archive Date: | Jan 28, 2025 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $225,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | City or township governments County governments For profit organizations other than small businesses Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Public and State controlled institutions of higher education Private institutions of higher education Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) State governments Small businesses Special district governments Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
The purpose of this Notice of Funding Opportunity (NOFO) is to support the development of a comprehensive and well-defined product development strategy for next-generation treatments for HIV and HIV-associated comorbidities, coinfections and complication and preventive strategies for HIV, as well as facilitating the translation of research findings into drug products that enables submission of an Investigational New Drug (IND) application to the FDA. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-24-029.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Modification to close date | Dec 30, 2024 | |
| Aug 15, 2023 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-24-029 |
| Funding Opportunity Title: | Planning for Product Development Strategy (R34 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Aug 15, 2023 |
| Last Updated Date: | Dec 30, 2024 |
| Original Closing Date for Applications: | Dec 04, 2026 |
| Current Closing Date for Applications: | Dec 29, 2024 |
| Archive Date: | Jan 28, 2025 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $225,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | City or township governments County governments For profit organizations other than small businesses Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Public and State controlled institutions of higher education Private institutions of higher education Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) State governments Small businesses Special district governments Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
The purpose of this Notice of Funding Opportunity (NOFO) is to support the development of a comprehensive and well-defined product development strategy for next-generation treatments for HIV and HIV-associated comorbidities, coinfections and complication and preventive strategies for HIV, as well as facilitating the translation of research findings into drug products that enables submission of an Investigational New Drug (IND) application to the FDA. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-24-029.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-24-029 |
| Funding Opportunity Title: | Planning for Product Development Strategy (R34 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 15, 2023 |
| Last Updated Date: | Aug 15, 2023 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Dec 04, 2026 |
| Archive Date: | Jan 09, 2027 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $225,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal governments (Federally recognized) City or township governments For profit organizations other than small businesses State governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Independent school districts Public housing authorities/Indian housing authorities Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) County governments Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Notice of Funding Opportunity (NOFO) is to support the development of a comprehensive and well-defined product development strategy for next-generation treatments for HIV and HIV-associated comorbidities, coinfections and complication and preventive strategies for HIV, as well as facilitating the translation of research findings into drug products that enables submission of an Investigational New Drug (IND) application to the FDA. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-24-029.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Related Documents
Folder 349870 Full Announcement-PAR-24-029 -> PAR-24-029-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or before January 24, 2025 | PKG00282875 | Feb 13, 2024 | Dec 31, 2024 | View | |
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00289018 | Nov 25, 2024 | Dec 31, 2024 | View |
Package 1
Mandatory forms
349870 RR_SF424_5_0-5.0.pdf
349870 PHS398_CoverPageSupplement_5_0-5.0.pdf
349870 RR_OtherProjectInfo_1_4-1.4.pdf
349870 PerformanceSite_4_0-4.0.pdf
349870 RR_KeyPersonExpanded_4_0-4.0.pdf
349870 PHS398_ResearchPlan_5_0-5.0.pdf
349870 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
349870 RR_Budget_3_0-3.0.pdf
349870 RR_SubawardBudget30_3_0-3.0.pdf
349870 PHS398_ModularBudget_1_2-1.2.pdf
349870 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
349870 RR_SF424_5_0-5.0.pdf
349870 PHS398_CoverPageSupplement_5_0-5.0.pdf
349870 RR_OtherProjectInfo_1_4-1.4.pdf
349870 PerformanceSite_4_0-4.0.pdf
349870 RR_KeyPersonExpanded_4_0-4.0.pdf
349870 PHS398_ResearchPlan_5_0-5.0.pdf
349870 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
349870 RR_Budget_3_0-3.0.pdf
349870 RR_SubawardBudget30_3_0-3.0.pdf
349870 PHS398_ModularBudget_1_2-1.2.pdf
349870 PHS_AssignmentRequestForm_4_0-4.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
